NYSEReal EstateReit - SpecialtySnapshot 2026-07-31
Reading WY? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Real Estate is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain full year 2026 Adjusted EBITDA at approximately $425 million: metric not reported.
View ThesisRevenue is contracting — down about 3% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 28%, softest on free-cash-flow margins.
View QualityManagement screens strong on earnings delivery, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 46% growth a year, above the roughly 7% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskWeyerhaeuser's growth in wood products demand supports its earnings potential. The company beat Q2 estimates, indicating strong performance. It trades at 19× price to funds from operations, above the peer median of 13×. The market is pricing in more growth than expected, which looks full. A specific risk is the potential for a guidance cut, with a 21% miss probability. Peer multiples imply a price about 40% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. WY is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 13 analysts currently covering WY (as of Jul 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Real Estate (broad) — fair value, gap to price, and forward P/E.
Advances: Maintain full year 2026 Adjusted EBITDA at approximately $450 million
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Increases guidance aligns with management's growth objectives.
Advances: Maintain full year 2026 Adjusted EBITDA at approximately $450 million
Earnings beat supports full year 2026 Adjusted EBITDA goal.
Advances: Increase Adjusted EBITDA by $1.5 billion by 2030
Increased prices support EBITDA growth objective.
Advances: Achieve comparable Q2 earnings and Adjusted EBITDA to Q1 2026
Beating estimates indicates strong performance consistency.
Threatens: Maintain full year 2026 Adjusted EBITDA at approximately $425 million
Negative earnings revisions could impact future EBITDA targets.
Advances: Maintain 2026 Adjusted EBITDA at $425 million
Investor conference supports long-term EBITDA goals.
